Liquidia stock cratered 57.19% on Wednesday, closing at $30.26 versus $70.69 on 2026-09-29, after a federal court ruled against its YUTREPIA lung drug in a patent dispute with United Therapeutics. Volume surged to 22,770,901 shares, reshaping the technical picture across every timeframe.

Key takeaways

• Liquidia stock plunged 57.19% on Wednesday, closing at $30.26 from a prior close of $70.69, with volume reaching 22,770,901 shares.
• The daily RSI14 collapsed to 20.23, deep in oversold territory, while price closed well below the lower Bollinger Band at $49.45.
• Price sits beneath all major EMAs across daily, hourly, and 15-minute timeframes, confirming a structural…